Skip to content

C84.AA

Billable

Cutaneous T-cell lymphoma, unspecified, in remission

HCC Category Mapping

V28HCC 20Lung and Other Severe Cancers
0.000
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

A type of blood cancer affecting T-cells in the skin that is currently in remission (no active disease).

Coding Tips

  • Only assign this code when documentation explicitly states the patient is in remission or complete response
  • This code should not be used if there is any evidence of active disease or recurrence

Clinical Significance

Cutaneous T-cell lymphoma in remission remains a significant diagnosis for risk adjustment because it reflects an ongoing cancer history requiring surveillance. Even in remission, patients need regular dermatologic monitoring, blood work, and imaging to detect recurrence. Accurate coding of remission status distinguishes active disease burden from controlled disease.

Documentation Requirements

  • Provider must explicitly state 'in remission' or 'complete response' — absence of treatment alone is insufficient
  • Document date remission was achieved and method of confirmation (clinical exam, imaging, biopsy)
  • Specify original cutaneous T-cell lymphoma subtype if known (mycosis fungoides, Sezary syndrome, etc.)
  • Note ongoing surveillance plan and any maintenance therapy

Commonly Confused Codes

Code Hierarchy

Open C84.AA in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.